Previous Article | Next Article ![]()
J. Bacteriol., 07 1996, 3818-3828, Vol 178, No. 13
D Vinella, B Gagny, D Joseleau-Petit, R D'Ari and M Cashel
Mecillinam, a beta-lactam antibiotic specific to penicillin-binding protein
2 (PBP 2) in Escherichia coli, blocks cell wall elongation and, indirectly,
cell division, but its lethality can be overcome by increased levels of
ppGpp, the nucleotide effector of the stringent response. We have subjected
an E. coli K-12 strain to random insertional mutagenesis with a mini-Tn10
element. One insertion, which was found to confer resistance to mecillinam
in relA+ and relA strains, was mapped at 75.5 min on the E. coli map and
was located between the promoters and the coding sequence of the aroK gene,
which codes for shikimate kinase 1, one of two E. coli shikimate kinases,
both of which are involved in aromatic amino acid biosynthesis. The
mecillinam resistance conferred by the insertion was abolished in a delta
relA delta spoT strain completely lacking ppGpp, and it thus depends on the
presence of ppGpp. Furthermore, the insertion increased the ppGpp pool
approximately twofold in a relA+ strain. However, this increase was not
observed in relA strains, although the insertion still conferred mecillinam
resistance in these backgrounds, showing that mecillinam resistance is not
due to an increased ppGpp pool. The resistance was also abolished in an
ftsZ84(Ts) strain under semipermissive conditions, and the aroK::mini-Tn10
allele partially suppressed ftsZ84(Ts); however, it did not increase the
concentration of the FtsZ cell division protein. The insertion greatly
decreased or abolished the shikimate kinase activity of AroK in vivo and in
vitro. The two shikimate kinases of E. coli are not equivalent; the loss of
AroK confers mecillinam resistance, whereas the loss of Arol, does not.
Furthermore, the ability of the aroK mutation to confer mecillinam
resistance is shown to be independent of polar effects on operon expression
and of effects on the availability of aromatic amino acids or shikimic
acid. Instead, we conclude that the AroK protein has a second activity,
possibly related to cell division regulation, which confers mecillinam
sensitivity. We were able to separate the AroK activities mutationally with
an aroK mutant allele lacking shikimate kinase activity but still able to
confer mecillinam sensitivity.
Copyright © 1996, American Society for Microbiology
Mecillinam resistance in Escherichia coli is conferred by loss of a second activity of the AroK protein
Laboratory of Molecular Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-2785, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»